Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wright Medical Odyssey

This article was originally published in The Gray Sheet

Executive Summary

Tissue-preserving minimally-invasive surgery program for hip, knee and total joint resurfacing procedures debuts initially for use with the firm's Profemur hip system, which gained expanded 510(k) clearance in July. Separately, the firm plans a limited October launch of its Micronail wrist fracture repair device following 510(k) clearance, announced Aug. 17. A full launch will follow in January. The fixed-angle locking screw implant targets 300,000 annual U.S. wrist fractures traditionally treated with casts and allows wrist use within a week of surgery...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020819

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel